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Abstract 
Background:  The role of the pharmacist is changing.  They are assuming greater roles and 
responsibilities.  These roles and responsibilities have not been established or evaluated in the 
private sector in South Africa. 
Objectives:  To determine whether there was a decrease in the rand-value of the monthly 
credits (medications not used by the patient and returned to the pharmacy for a credit) for the 
ICU pre- and post-implementation of clinical pharmacy services.   
To determine whether there was a decrease in the number of daily scripts from the ICU 
reaching the pharmacy pre- and post-implementation of clinical pharmacy services.   
To determine whether there was a decrease in the average ICU stay (a decrease in the average 
amount of days that the patient spends in ICU) pre- and post-implementation of clinical 
pharmacy services. 
 
To compare the total medication bill of patients pre- and post-implementation of clinical 
pharmacy services.  Patients with the same type of diseases were grouped and compared. 
 
A breakdown of the classes of the drugs used pre- and post-implementation of clinical 
pharmacy services were given and the amount of each drug and the rand value over both 
years were explored.   
 
To assess the incidence of interventions performed by a pharmacist during the provision of 
clinical pharmacy services. 
 
To determine the need of a clinical pharmacist by the number of interventions made. 
Method:  
Aims 
To determine whether there is a need for a clinical pharmacist in the intensive care unit. 
To determine whether there were cost-savings involved with a clinical pharmacist attending 
to the intensive care unit. 
 iv 
 
Study site 
The study was conducted in the intensive care units at a private hospital in Pretoria.  The 
intensive care units consists out of the Medical ICU (11 beds) and the Trauma ICU (17 beds). 
Study design 
The design of the study was quantitative and non-experimental.  Data were collected 
retrospectively. 
Study period 
Patients admitted to the ICU one year before (October 2008 – September 2009) and one year 
after (October 2009 – September 2010) the implementation of dedicated ICU pharmacy 
services were retrospectively reviewed.  Clinical pharmacy services were implemented from 
the 1
st
 of October 2009. 
Sample population 
The records of all patients, adults and children, admitted to the ICU unit over the study period 
October 2008 to September 2010 were included. 
Results: 
ICU stay and diagnoses 
Average ICU days for the year pre-clinical pharmacy services were 5.56 days per patient and 
for the year post-clinical pharmacy services 5.25 days per patient.  The two groups were very 
similar regarding ICU days. 
Patients with the same type of diseases were grouped and compared. 
Monthly credits 
The total amount of credits in the year post-clinical pharmacy services, decreased with an 
amount of R335 160.30.  That equals a decrease of 48.86%. 
Number of daily scripts 
There was a decrease of 809 prescriptions in the year post-clinical pharmacy services. 
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Breakdown of the classes of drugs 
The total number of items dispensed in the year post-clinical pharmacy services decreased 
with 19 678 items. 
The stock value for the year post-clinical pharmacy services decreased with R1 595 622. 
Total medication bill 
The ICU drug total for the year pre-clinical pharmacy services was R14 563 687.  The ICU 
drug total for the year post-clinical pharmacy services was R13 030 335.39.  The total 
decreased with R1 533 351.61. 
Interventions made by the clinical pharmacist 
The clinical pharmacist made 349 interventions for the year post-clinical pharmacy services, 
compared to the 105 interventions made by the nursing staff and attending physicians for the 
year pre-clinical pharmacy services.  These interventions included detection or prevention of 
allergies, clinical recommendations, detecting of dispensing errors, detecting of dosing errors, 
duplicate therapy and transcribing errors. 
Conclusions:  There is a need for clinical pharmacy services in a private hospital.  The 
pharmacist positively contributes to and is directly involved in the care of critically ill 
patients.  Pharmacy education programmes in South Africa will have to be adjusted to 
accommodate this new branch of pharmacy. 
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